h-ser-asp-ala-ala-val-asp-thr-ser-ser-glu-ile-thr-thr-lys-asp-leu-lys-glu-lys-lys-glu-val-val-glu-glu-ala-glu-asn-oh
74221-77-5
|
2-[2-[[2-[[2-[(2-amino-3-methylbutanoyl)amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]propanoylamino]pentanedioic acid,azane
100930-17-4
|
h-his-his-gly-val-val-glu-val-asp-ala-ala-val-thr-pro-glu-glu-arg-his-leu-ser-lys-oh
158561-91-2
|
VAL-HIS-LEU-THR-PRO-VAL-GLU-LYS
62526-81-2
|
VAL-GLU-PRO-ILE-PRO-TYR
94773-24-7
|
Val-Val-Asp(OBzl)-OBzl
70853-23-5
|
Val-Val-Tyr-Pro-Asp-OH
193750-11-7
|
NFAT Inhibitor trifluoroacetate salt
249537-73-3
|
[D-Ala2] -Deltorphin II
122752-16-3
|
3-Fluoro-1-(m-tolyl)cyclobutanamine
1707364-74-6
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
2-(2-aminoethyl)-6-methyl-5,6,7,8-tetrahydrocinnolin-3(2H)-one
1443290-32-1
|
2-(cyclopentyloxy)-N-(2,6-difluorophenyl)isonicotinamide
2034443-80-4
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
alpha-Bromo-alpha-trifluoroacetyl-delta-valerolactone, hydrate
1820649-09-9
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
